Navigation Links
Contrast Media / Contrast Agents Market (Interventional Radiology & Interventional Cardiology) worth $8.6 Billion by 2017 - New Report by MarketsandMarkets
Date:9/1/2013

(PRWEB) September 01, 2013

According to a new market research report “Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium and Barium), By Technique (X-ray, CT, MRI, Cath Lab and Ultrasound) and By Application (Radiology, Interventional Radiology and Interventional Cardiology) - Global Trends and Forecast to 2017” analyzes and studies the major market drivers, restraints, opportunities and technology trends in North America, Europe, APAC and Rest of the World.

Browse 107 Market Data Tables with 14 Figures spread through 286 Pages and in-depth TOC on "Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium and Barium), By Technique (X-ray, CT, MRI, Cath Lab and Ultrasound) and By Application (Radiology, Interventional Radiology and Interventional Cardiology) - Global Trends and Forecast to 2017". Download a free sample report for Contrast Media / Contrast Agents Market.

Early buyers will receive 10% customization on this report.

This report studies the global contrast media / contrast agents market over the forecast period of 2012 to 2017.

Contrast media signify a vital requirement of medical imaging as these agents provide better images of body structures and organs when visualized during medical procedures like X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and catheterization laboratory (cath lab) procedures. This market has been segmented into three product categories - barium-based, iodinated and gadolinium-based contrast media. These product segments are further bifurcated based on their routes of administration (oral, injection, rectal, and urethral), indication (cardiovascular, neurology, oncology, respiratory, nephrology, gastrointestinal, and musculoskeletal), medical procedure (X-ray, CT, MRI, ultrasound, and cath lab) and application (radiology, interventional radiology, and interventional cardiology). The global contrast media market boasts of a total value of $6.2 billion in 2012 and is expected to register a growth rate of 6.8% to reach a value of $8.6 billion by 2017.

North America accounted for the largest share, followed by Europe. This is attributed to the fact that major players are located in these regions with easy access and extensive use of contrast media in almost all radiological examinations. Europe is expected to grow at the lowest CAGR globally, mainly due to the impact of economic slowdown in this region and the probable delay in the adoption of new products and technology in the contrast media arena.

The global contrast media market, though fairly mature at present (2012), still shows potential to grow over the next five years. It is propelled by the increasing demand for diagnostic imaging and image guided surgical procedures, technological advances in diagnostic imaging and the ever-increasing incidence rates of cancer and cardiac disorders. However, a few pivotal factors affecting the growth of this market are major economies of the world undergoing healthcare reforms, thereby affecting contrast media sales and the economic slowdown restricting the overall growth of this market.

In competitive landscape, we have studied the growth strategies adopted by the companies between 2010 and 2012. Players in this market have adopted various strategies to expand their global footprint and increase their market share. New product launch, partnerships and alliances, mergers and acquisitions, and other developments are some of the major strategies adopted by player to achieve growth.

The major players profiled in this report are GE Healthcare (U.K.), Bracco Diagnostic, Inc. (Italy), Bayer Healthcare Pharmaceuticals (Germany), Covidien (Ireland) and Guerbet Group (France).

Browse related reports

Dietary Fiber Market by Product Type (Conventional/ Novel & Soluble/ Insoluble) and Application (Food & Pharmaceuticals) - Global Trends & Forecasts up to 2017
http://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html

Radiation Detection, Monitoring & Safety Market for Nuclear Power Plants, Homeland Security & Defense, Manufacturing Industry (Geiger Counter, Scintillator, Dosimeter, Area Process, Survey Meter, Portal Monitors) - Trends & Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/radiation-protection-market-987.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including agriculture, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare-it/medical-devices
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets

Read the full story at http://www.prweb.com/releases/contrast-media/contrast-agents-market/prweb11078260.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Contrast-enhanced ultrasound monitors aortic aneurysm treatment
2. High-contrast, high-resolution CT scans now possible at reduced dose
3. Contrast Media/Agents Market is Estimated to Grow at a CAGR of 6.8% & to Reach $8.6 Billion By 2017 - by MarketsandMarkets
4. Classe Wines Announces Availability of 2008 Vitivinicola Carla Rita Ferreira Contraste Vinho Tinto
5. Risk of suicide and fatal heart attack immediately following a cancer diagnosis
6. Media registration now open for TCT 2012
7. Media Multitasking Might Have Mental Upside
8. The Science Media Centre, London, wins the 2012 ECNP Media Award
9. ESC Congress 2012 media alert
10. Probing the mechanism of ADAM28-mediated cancer metastasis
11. Eating garbage: Bacteria for bioremediation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology: